search
Back to results

Trocar Site Incisional Hernia Prevention (PHIT)

Primary Purpose

Incisional Hernia

Status
Recruiting
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Hincisional hernia prevention by onlay prosthesis trocar closure
laparoscopic cholecystectomy
Abdominal ultrasound
Sponsored by
Hospital Universitari Joan XXIII de Tarragona.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Incisional Hernia focused on measuring Incisional Hernia, Umbilical Trocar, Preventive mesh

Eligibility Criteria

18 Years - 99 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Patients undergoing elective laparoscopic cholecystectomy, with or without an exploration of the common bile duct, undergoing surgery in our hospital
  • ASA (American Society of Anesthesiologists) <IV

Exclusion Criteria:

  • Allergy or intolerance to any of the mesh components
  • Patients presenting already primary or incisional hernia of the abdominal wall
  • ASA ≥IV
  • Intraoperative conversion to laparotomy
  • Emergency surgery
  • Pregnancy

Sites / Locations

  • Pius, Hospital de VallsRecruiting
  • Hospital Universitari de Tarragona Joan XXIIIRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Prosthesis

Control

Arm Description

Firstly, a laparoscopic cholecystectomy is performed. After suturing the aponeurosis with a J needle and 0 Polydioxanone, a lightweight, large-pore mesh made of PVDF monofilament (polyvinylidene fluoride - DynaMesh-CICAT, FEC Textiltechnik, Germany) will be placed onlay, overlapping 2cm in all directions from the edge of the aponeurosis incision at the umbilical trocar site. The mesh will be fixed to the aponeurosis with cyanoacrylate glue (Glubran®, GEM, Viareggio, Italy).

Firstly, a laparoscopic cholecystectomy is performed. Closure of the aponeurosis will be performed by standard procedure: under direct vision, suturing the aponeurosis with a J needle and 0 Polydioxanone, with a stitch interval of ≤ 5mm.

Outcomes

Primary Outcome Measures

Incidence of incisional hernia
The primary endpoint is the incidence of incisional hernia in the 2 groups. Because incisional hernia may occur within the first months after surgery, assessment will be carried out during scheduled clinical visits over 12 months. The presence of incisional hernia will be evaluated by physical examination and radiologically by an abdominal US scan performed at the end of follow-up (12 months after operation).

Secondary Outcome Measures

Perioperative complications
Secondary endpoints will be perioperative complications, including wound infection, haematoma, pain and reoperation.
Economical impact
We will compare on one side the cost of the mesh and the glue and on the other side the costs of reoperation and hospital stay in case of appearance of incisional hernias.

Full Information

First Posted
January 6, 2021
Last Updated
September 23, 2023
Sponsor
Hospital Universitari Joan XXIII de Tarragona.
Collaborators
Institut de Diagnòstic per la Imatge (IDI), Institut Investigacio Sanitaria Pere Virgili
search

1. Study Identification

Unique Protocol Identification Number
NCT04699201
Brief Title
Trocar Site Incisional Hernia Prevention
Acronym
PHIT
Official Title
Prevenció de l'Hèrnia Incisional Per Tròcar
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
March 2, 2021 (Actual)
Primary Completion Date
November 2023 (Anticipated)
Study Completion Date
February 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Hospital Universitari Joan XXIII de Tarragona.
Collaborators
Institut de Diagnòstic per la Imatge (IDI), Institut Investigacio Sanitaria Pere Virgili

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Objective: To test the preventive effect of the placement of an onlay mesh versus the use of a fascial closure device at the umbilical trocar site closure in order to prevent incisional hernia after laparoscopic surgery. Methods: We designed a Two Center Randomized Controlled Trial were adult participants presenting for elective laparoscopic cholecystectomy, with or without an exploration of the common bile duct will be recruited, with allocation of each of them in 2 groups (prosthesis and control). Abdominal ultrasound scan focused on aponeurosis defects at the trocar sites will be performed at 12 postoperative months. An ultrasound scan will be performed to avoid underdiagnosis bias since incisional hernia is frequently under detected by clinical examination. Relevance: The prevalence of incisional hernia after laparoscopy might be as high as 30%, due to this reason is paramount to find a better closure technique. There are few studies about incisional hernia including radiological exams in order to provide the exact prevalence of this pathology, even fewer literature exists about incisional hernia after laparoscopic procedures.
Detailed Description
OBJECTIVE To test the preventive effect of the placement of an onlay mesh at the time of umbilical trocar site closure in order to prevent incisional hernia after laparoscopic surgery. The estimated prevalence of incisional hernia after laparoscopy is 15- 25%, being even higher among patients with risk factors. Many different closure techniques exist, however few of them have been tested in Randomised Control Trials. Most of them lack an image technique to provide more accurate results. METHODOLOGY We designed a Two Center, Randomized Controlled Trial that will enroll patients undergoing laparoscopic cholecystectomy, with or without an exploration of the common bile duct. Participants will be randomized to 2 groups. The pneumoperitoneum technique will be achieved by Hasson technique. The closure procedure will take place at the end of the surgery, after the cholecystectomy is performed: Prosthesis: after suturing the aponeurosis with a J needle and 0 Polydioxanone, a lightweight, large-pore mesh made of PVDF monofilament (polyvinylidene fluoride - DynaMesh-CICAT, FEC Textiltechnik, Germany) will be placed onlay, overlapping 2cm in all directions from the edge of the aponeurosis incision at the umbilical trocar site. The mesh will be fixed to the aponeurosis with cyanoacrylate glue (Glubran®, GEM, Viareggio, Italy). Control: Closure of the aponeurosis will be performed by standard procedure: under direct vision, suturing the aponeurosis with a J needle and 0 Polydioxanone, with a stitch interval of ≤ 5mm. An abdominal ultrasound scan focused on aponeurosis defects at the trocar sites will be performed at 12 postoperative months. Minimum follow-up will be 12 months. All the adverse events will be registered and classified according to the Clavien Dindo classification. An ultrasound scan will be performed to avoid underdiagnosis bias since incisional hernia is frequently under detected by clinical examination. Relevance: The prevalence of incisional hernia after laparoscopy might be as high as 30%, due to this reason is paramount to find a better closure technique. There are few studies about incisional hernia including radiological exams in order to provide the exact prevalence of this pathology, even fewer literature exists about incisional hernia after laparoscopic procedures. Univariate descriptive analysis will present the results as means (with standard deviation and range) for the continuous variables and as numbers and percentages for the categorical variables. Bivariate analysis will be carried out among the variables of interest to describe their level of correlation and evaluate the possible differences between them. To evaluate the differences between the continuous variables we will use the comparison of means based on the T-Student and for the comparison of categorical variables the Chi-square test. Finally, linear regression models and generalized linear models (as appropriate depending on the response variable) will be used to study the dependence of the variables of interest, with other factors of study. Statistical analysis will be carried out using the SPSS (Statistical Package for the Social Sciences) Software (IBM SPSS Statistics 23). All tests will be bilateral with a level of significance of 5%. 100% of the data recorded will be analyzed, and the proportion of values lost in the variables of interest will be evaluated.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Incisional Hernia
Keywords
Incisional Hernia, Umbilical Trocar, Preventive mesh

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Bicentric Randomized Controlled Trial. 2 allocation groups, parallel. Single blind. Enrollment: consecutive cases Time Perspective: Prospective
Masking
Participant
Masking Description
The participant will not know if the umbilical incision has been close by standard technique or with the preventive mesh. Also the radiologists performing the ultrasounds after 12 months will not have the information of Prosthesis/Control patient allocation
Allocation
Randomized
Enrollment
94 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Prosthesis
Arm Type
Experimental
Arm Description
Firstly, a laparoscopic cholecystectomy is performed. After suturing the aponeurosis with a J needle and 0 Polydioxanone, a lightweight, large-pore mesh made of PVDF monofilament (polyvinylidene fluoride - DynaMesh-CICAT, FEC Textiltechnik, Germany) will be placed onlay, overlapping 2cm in all directions from the edge of the aponeurosis incision at the umbilical trocar site. The mesh will be fixed to the aponeurosis with cyanoacrylate glue (Glubran®, GEM, Viareggio, Italy).
Arm Title
Control
Arm Type
Active Comparator
Arm Description
Firstly, a laparoscopic cholecystectomy is performed. Closure of the aponeurosis will be performed by standard procedure: under direct vision, suturing the aponeurosis with a J needle and 0 Polydioxanone, with a stitch interval of ≤ 5mm.
Intervention Type
Procedure
Intervention Name(s)
Hincisional hernia prevention by onlay prosthesis trocar closure
Intervention Description
Hincisional hernia prevention by onlay prosthesis trocar closure
Intervention Type
Procedure
Intervention Name(s)
laparoscopic cholecystectomy
Intervention Description
Laparoscopic cholecystectomy with or without common bile duct exploration
Intervention Type
Diagnostic Test
Intervention Name(s)
Abdominal ultrasound
Intervention Description
Ultrasound focused in abdominal wall defects on the trocar incisions, 12 months after the surgery
Primary Outcome Measure Information:
Title
Incidence of incisional hernia
Description
The primary endpoint is the incidence of incisional hernia in the 2 groups. Because incisional hernia may occur within the first months after surgery, assessment will be carried out during scheduled clinical visits over 12 months. The presence of incisional hernia will be evaluated by physical examination and radiologically by an abdominal US scan performed at the end of follow-up (12 months after operation).
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Perioperative complications
Description
Secondary endpoints will be perioperative complications, including wound infection, haematoma, pain and reoperation.
Time Frame
30 days
Title
Economical impact
Description
We will compare on one side the cost of the mesh and the glue and on the other side the costs of reoperation and hospital stay in case of appearance of incisional hernias.
Time Frame
12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
99 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Patients undergoing elective laparoscopic cholecystectomy, with or without an exploration of the common bile duct, undergoing surgery in our hospital ASA (American Society of Anesthesiologists) <IV Exclusion Criteria: Allergy or intolerance to any of the mesh components Patients presenting already primary or incisional hernia of the abdominal wall ASA ≥IV Intraoperative conversion to laparotomy Emergency surgery Pregnancy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Joan Ferreres Serafini, MD
Phone
(+34) 657920793
Email
joanfs8@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Rosa Jorba Martin, MD
Email
rjorba.hj23.ics@gencat.cat
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Carles Olona Casas, MD
Organizational Affiliation
Hospital Universitari de Tarragona
Official's Role
Study Director
Facility Information:
Facility Name
Pius, Hospital de Valls
City
Valls
State/Province
Tarragona
ZIP/Postal Code
43800
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Joan Ferreres Serafini, MD
Phone
657920793
Email
joanfs8@gmail.com
Facility Name
Hospital Universitari de Tarragona Joan XXIII
City
Tarragona
ZIP/Postal Code
43005
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Joan Ferreres Serafini, MD
Phone
657920793
Email
joanfs8@gmail.com

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Trocar Site Incisional Hernia Prevention

We'll reach out to this number within 24 hrs